ACADIA Pharmaceuticals Inc. (ACAD)
| Previous close | 27.24 |
| Open | 27.36 |
| Bid | 26.66 x 1000 |
| Ask | 26.73 x 3100 |
| Day's range | 26.68 - 27.10 |
| 52-week range | 19.20 - 58.72 |
| Volume | 49,905 |
| Avg. volume | 2,169,900 |
| Market cap | 4.277B |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.64 |
| Earnings date | 03 Aug 2021 - 09 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.16 |
- Business Wire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Jun 12, 2021--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of investors that purchased Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) securities between June 15, 2020 and April 4, 2021, inclusive (the "Class Period"). Investors have until June 18, 2021 to apply to the Court to be appointed as lead plaintiff
- Business Wire
ACAD BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action – ACAD
NEW YORK, Jun 11, 2021--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021, inclusive (the "Class Period") of the important June 18, 2021 lead plaintiff deadline.
- Zacks
Why Is Acadia (ACAD) Up 11.3% Since Last Earnings Report?
Acadia (ACAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
